Medtronic receives FDA warning letter over quality control issues at diabetes HQ

The warning letter was the result of an inspection of the Southern California facility that the FDA completed in July, related to a pair of Class I recalls issued for several models of Medtronic’s MiniMed insulin pumps.

Related Keywords

California ,United States ,Medtronic Minimed ,Sean Salmon ,Medtronic ,Los Angeles Area ,Triple Jump ,Southern California ,Minimed Paradigm ,Food And Drug Administration Fda ,Diabetes ,Insulin Pump ,Classi Recall ,Fda Warning ,Medtech ,